Distal hereditary motor neuropathy type 1

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:139518OMIM:182960G12.2
Who is this for?
Show terms as
1Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Distal hereditary motor neuropathy type 1 (dHMN1), also known as distal spinal muscular atrophy type 1 or spinal muscular atrophy, distal, autosomal recessive 1, is a rare inherited neuromuscular disorder characterized by progressive weakness and wasting (atrophy) of muscles in the distal parts of the limbs, particularly the hands and feet. Unlike other motor neuron diseases, dHMN1 predominantly affects the lower motor neurons without significant sensory nerve involvement, distinguishing it from hereditary motor and sensory neuropathies (such as Charcot-Marie-Tooth disease). The condition falls under the broader category of spinal muscular atrophies (ICD-10: G12.2). The disease primarily affects the peripheral nervous system, specifically the motor neurons that control voluntary muscle movement. Key clinical features include progressive distal muscle weakness beginning in the lower limbs, foot deformities such as pes cavus (high-arched feet), difficulty walking, and eventual involvement of the hands and forearms. Muscle wasting tends to progress slowly over years, and deep tendon reflexes may be reduced or absent in affected areas. Sensation typically remains intact, which is an important distinguishing feature. There is currently no cure or disease-modifying treatment for dHMN1. Management is supportive and symptomatic, focusing on physical therapy to maintain mobility and muscle strength, occupational therapy for hand function, orthotic devices such as ankle-foot orthoses to assist with walking, and surgical interventions for skeletal deformities when necessary. Genetic counseling is recommended for affected families. The prognosis varies, but the condition is generally slowly progressive and life expectancy is usually not significantly reduced.

Also known as:

Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Juvenile

Begins in the teen years

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Distal hereditary motor neuropathy type 1.

View clinical trials →

No actively recruiting trials found for Distal hereditary motor neuropathy type 1 at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Distal hereditary motor neuropathy type 1 community →

Specialists

1 foundView all specialists →
CP
Chiara Marini-Bettolo, MD, PhD
Newcastle upon Tyne
Specialist

Rare Disease Specialist

PI on 3 active trials

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Distal hereditary motor neuropathy type 1.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Distal hereditary motor neuropathy type 1Forum →

No community posts yet. Be the first to share your experience with Distal hereditary motor neuropathy type 1.

Start the conversation →

Latest news about Distal hereditary motor neuropathy type 1

No recent news articles for Distal hereditary motor neuropathy type 1.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Distal hereditary motor neuropathy type 1

What is Distal hereditary motor neuropathy type 1?

Distal hereditary motor neuropathy type 1 (dHMN1), also known as distal spinal muscular atrophy type 1 or spinal muscular atrophy, distal, autosomal recessive 1, is a rare inherited neuromuscular disorder characterized by progressive weakness and wasting (atrophy) of muscles in the distal parts of the limbs, particularly the hands and feet. Unlike other motor neuron diseases, dHMN1 predominantly affects the lower motor neurons without significant sensory nerve involvement, distinguishing it from hereditary motor and sensory neuropathies (such as Charcot-Marie-Tooth disease). The condition fall

How is Distal hereditary motor neuropathy type 1 inherited?

Distal hereditary motor neuropathy type 1 follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Distal hereditary motor neuropathy type 1 typically begin?

Typical onset of Distal hereditary motor neuropathy type 1 is juvenile. Age of onset can vary across affected individuals.

Which specialists treat Distal hereditary motor neuropathy type 1?

1 specialists and care centers treating Distal hereditary motor neuropathy type 1 are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.